Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
100%
ErbB Receptors
74%
Protein-Tyrosine Kinases
56%
Vascular Endothelial Growth Factor A
50%
Neoplasms
48%
HM781-36B
48%
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
38%
Epithelial-Mesenchymal Transition
34%
Mutation
31%
Adenocarcinoma of Lung
25%
Cell Line
24%
Erlotinib Hydrochloride
24%
Vascular Endothelial Growth Factor Receptor
21%
osimertinib
21%
Small Cell Lung Carcinoma
21%
Therapeutics
20%
Enhancer of Zeste Homolog 2 Protein
19%
Neuroblastoma
19%
Heterografts
18%
Exons
18%
Interleukin-6
17%
Vascular Endothelial Growth Factor Receptor-2
17%
Progression-Free Survival
16%
Bevacizumab
16%
Lung Neoplasms
15%
Proteomics
15%
Growth
15%
Vascular Remodeling
15%
Endothelial Cells
13%
Phosphatidylinositol 3-Kinases
13%
Hormones
13%
Carcinoma
13%
Neoplasm Metastasis
13%
Survival
13%
Pharmaceutical Preparations
13%
Hypoxia-Inducible Factor 1
12%
Adenosine
12%
Biomarkers
12%
AEE 788
11%
Platinum
11%
Forkhead Box Protein M1
11%
polo-like kinase 1
10%
Phenotype
10%
Squamous Cell Carcinoma
10%
Drug Therapy
9%
Tumor Microenvironment
8%
Dasatinib
8%
M Phase Cell Cycle Checkpoints
8%
Receptor Protein-Tyrosine Kinases
8%
Isotretinoin
8%